Signalling pathways for insulin-like growth factor type 1-mediated expression of uncoupling protein 3

被引:15
|
作者
Gustafsson, H [1 ]
Tamm, C [1 ]
Forsby, A [1 ]
机构
[1] Stockholm Univ, Dept Neurochem & Neurotoxicol, SE-10691 Stockholm, Sweden
关键词
IGF-1; MAP kinase; oxidative stress; PI3-kinase; SH-SY5Y; uncoupling protein;
D O I
10.1046/j.1471-4159.2003.02162.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Uncoupling protein 3 (UCP3) is a mitochondrial protein with antioxidant properties and its regulation by factors promoting cell-survival may be important for protection of, for instance, neurons in states of oxidative stress. In the present study, we investigated regulatory pathways for UCP3 expression mediated by the neuroprotective hormone insulin-like growth factor type 1 (IGF-1) in human neuroblastoma SH-SY5Y cells. Northern blot analysis and RT-PCR showed that treatment with 10 nm IGF-1 increased the UCP3 mRNA levels 2.5-fold after 5 h. Co-incubation with the phosphatidylinositol 3 (PI3)-kinase inhibitor LY294002 prohibited IGF-1-mediated induction of both UCP3 mRNA and protein in a concentration-dependent manner, with a complete blockage at 1 mum, as shown by RT-PCR and western blot analyses. The mitogen-activated protein (MAP) kinase kinase 1 (MKK1 or MEK) inhibitor PD98059 also decreased the UCP3 mRNA expression at 10 mum, however, this concentration only partly inhibited the protein expression. We conclude that IGF-1 enhanced UCP3 expression at transcriptional level, primarily through the PI3-kinase-dependent pathway and partly through the MAP kinase pathway.
引用
收藏
页码:462 / 468
页数:7
相关论文
共 50 条
  • [41] Evaluation of Serum Levels of Insulin-Like Growth Factor 1 and Insulin-Like Growth Factor-Binding Protein 3 in Patients With Colorectal Cancer: A Case-Control Study
    Naguib, Rania
    Abouegylah, Mohamed
    Sharkawy, Sherif
    Fayed, Amel A.
    Naguib, Hend
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (11)
  • [42] Expression of insulin-like growth factor-1 and insulin-like growth factor binding proteins in the serum and cerebrospinal fluid of patients with Parkinson's disease
    Mashayekhi, Farhad
    Mirzajani, Ebrahim
    Naji, Mohammad
    Azari, Majid
    JOURNAL OF CLINICAL NEUROSCIENCE, 2010, 17 (05) : 623 - 627
  • [43] Serum Levels of Insulin-like Growth Factor 1 and Insulin-like Growth Factor-binding Protein 2 as a Novel Biomarker in the Detection of Pancreatic Adenocarcinoma
    Wlodarczyk, Barbara
    Borkowska, Anna
    Wlodarczyk, Przemyslaw
    Malecka-Panas, Ewa
    Gasiorowska, Anita
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2020, 54 (09) : E83 - E88
  • [44] Comparison of effects of the rise in serum testosterone by raloxifene and oral testosterone on serum insulin-like growth factor-1 and insulin-like growth factor binding protein-3
    Duschek, EJJ
    Gooren, LJ
    Netelenbos, C
    MATURITAS, 2005, 51 (03) : 286 - 293
  • [45] Genetically predicted high circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 increase the risks of soft tissue sarcoma
    Xu, Yifan
    Tsai, Chia-Wen
    Chang, Wen-Shin
    Xiong, Grace Y.
    Huang, Maosheng
    Torres, Keila E.
    Bau, Da-Tian
    Gu, Jian
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (08): : 3980 - +
  • [46] Heart Smart Insulin-Like Growth Factor 1
    Marsh, Susan A.
    Davidoff, Amy J.
    HYPERTENSION, 2012, 59 (03) : 550 - 551
  • [47] Insulin-like growth factor-1 in CNS and cerebrovascular aging
    Sonntag, William E.
    Deak, Ferenc
    Ashpole, Nicole
    Toth, Peter
    Csiszar, Anna
    Freeman, Willard
    Ungvari, Zoltan
    FRONTIERS IN AGING NEUROSCIENCE, 2013, 5
  • [48] Impact of insulin-like growth factor 1 and insulin-like growth factor binding proteins on outcomes in acute myeloid leukemia
    Karmali, Reem
    Larson, Melissa L.
    Shammo, Jamile M.
    Basu, Sanjib
    Christopherson, Kent
    Borgia, Jeffrey A.
    Venugopal, Parameswaran
    LEUKEMIA & LYMPHOMA, 2015, 56 (11) : 3135 - 3142
  • [49] CLINICAL SIGNIFICANCE OF SERUM INSULIN-LIKE GROWTH FACTOR-1 (IGF-1) AND INSULIN-LIKE GROWTH BINDING PROTEIN-3 (IGFBP-3) IN PATIENTS WITH GASTRIC CANCER
    Bademler, Suleyman
    Sari, Murat
    Ucuncu, Muhammet Zubeyr
    Serilmez, Murat
    Karabulut, Senem
    ACTA MEDICA MEDITERRANEA, 2018, 34 (06): : 2055 - 2060
  • [50] Insulin-Like Growth Factor-1 and Central Neurodegenerative Diseases
    Torres Aleman, Ignacio
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2012, 41 (02) : 395 - +